标题
Targeting the Inflammasome in Cardiovascular Disease
作者
关键词
-
出版物
JACC-Basic to Translational Science
Volume 7, Issue 1, Pages 84-98
出版商
Elsevier BV
发表日期
2021-11-04
DOI
10.1016/j.jacbts.2021.08.006
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Universal Definition and Classification of Heart Failure
- (2021) Biykem Bozkurt et al. JOURNAL OF CARDIAC FAILURE
- AIM2 controls microglial inflammation to prevent experimental autoimmune encephalomyelitis
- (2021) Chunmei Ma et al. JOURNAL OF EXPERIMENTAL MEDICINE
- NLRP3 Inflammasome Inhibitors in Cardiovascular Diseases
- (2021) Eleonora Mezzaroma et al. MOLECULES
- AIM2 in regulatory T cells restrains autoimmune diseases
- (2021) Wei-Chun Chou et al. NATURE
- Randomized Trial of Interleukin-6 Receptor Inhibition in Patients With Acute ST-Segment Elevation Myocardial Infarction
- (2021) Kaspar Broch et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- DPP9 sequesters the C terminus of NLRP1 to repress inflammasome activation
- (2021) L. Robert Hollingsworth et al. NATURE
- Structural and biochemical mechanisms of NLRP1 inhibition by DPP9
- (2021) Menghang Huang et al. NATURE
- The AIM2 inflammasome exacerbates atherosclerosis in clonal haematopoiesis
- (2021) Trevor P. Fidler et al. NATURE
- Targeting Inflammatory Pathways in Cardiovascular Disease: The Inflammasome, Interleukin-1, Interleukin-6 and Beyond
- (2021) Peter Libby Cells
- Effect of Colchicine on Myocardial Injury in Acute Myocardial Infarction
- (2021) Nathan Mewton et al. CIRCULATION
- VX-765 attenuates atherosclerosis in ApoE deficient mice by modulating VSMCs pyroptosis
- (2020) Yiyi Li et al. EXPERIMENTAL CELL RESEARCH
- Single-cell reconstruction of the adult human heart during heart failure and recovery reveals the cellular landscape underlying cardiac function
- (2020) Li Wang et al. NATURE CELL BIOLOGY
- Therapeutic modulation of inflammasome pathways
- (2020) Dhruv Chauhan et al. IMMUNOLOGICAL REVIEWS
- Sex Differences in the Inflammatory Response: Pharmacological Opportunities for Therapeutics for Coronary Artery Disease
- (2020) Asad Shabbir et al. Annual Review of Pharmacology and Toxicology
- Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)
- (2020) Nadia Bouabdallaoui et al. EUROPEAN HEART JOURNAL
- Colchicine in Patients with Chronic Coronary Disease
- (2020) Stefan M. Nidorf et al. NEW ENGLAND JOURNAL OF MEDICINE
- Enteroviral 3C protease activates the human NLRP1 inflammasome in airway epithelia
- (2020) Kim S. Robinson et al. SCIENCE
- Cholesterol crystals use complement to increase NLRP3 signaling pathways in coronary and carotid atherosclerosis
- (2020) Nathalie Niyonzima et al. EBioMedicine
- Human NLRP1 is a sensor for double-stranded RNA
- (2020) Stefan Bauernfried et al. SCIENCE
- Inflammation and NLRP3 Inflammasome Activation Initiated in Response to Pressure Overload by Ca 2+ /Calmodulin-Dependent Protein Kinase II δ Signaling in Cardiomyocytes Are Essential for Adverse Cardiac Remodeling
- (2019) Takeshi Suetomi et al. CIRCULATION
- Cost-effectiveness of Canakinumab for Prevention of Recurrent Cardiovascular Events
- (2019) Thomas S. G. Sehested et al. JAMA Cardiology
- AIM2 gene silencing attenuates diabetic cardiomyopathy in type 2 diabetic rat model
- (2019) Xuyang Wang et al. LIFE SCIENCES
- MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition
- (2019) Rebecca C. Coll et al. Nature Chemical Biology
- The role of Caspase 1 in ischemia/reperfusion injury of the myocardium.
- (2019) Ali Rauf et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- NLRP3 inflammasome in cardioprotective signaling
- (2019) Coert J Zuurbier JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- NLRP3 Inflammasome Promotes Myocardial Remodeling During Diet-Induced Obesity
- (2019) Marina Sokolova et al. Frontiers in Immunology
- Residual inflammatory risk associated with interleukin-18 and interleukin-6 after successful interleukin-1β inhibition with canakinumab: further rationale for the development of targeted anti-cytokine therapies for the treatment of atherothrombosis
- (2019) Paul M Ridker et al. EUROPEAN HEART JOURNAL
- Atherosclerosis
- (2019) Peter Libby et al. Nature Reviews Disease Primers
- Interleukin‐18 in patients with acute coronary syndromes
- (2019) Axel Åkerblom et al. CLINICAL CARDIOLOGY
- Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction
- (2019) Jean-Claude Tardif et al. NEW ENGLAND JOURNAL OF MEDICINE
- Usefulness of Canakinumab to Improve Exercise Capacity in Patients With Chronic Systolic Heart Failure and Elevated C-Reactive Protein
- (2018) Cory Trankle et al. AMERICAN JOURNAL OF CARDIOLOGY
- The SGK1 inhibitor EMD638683, prevents Angiotensin II–induced cardiac inflammation and fibrosis by blocking NLRP3 inflammasome activation
- (2018) Wenqiang Gan et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- The Caspase 1 Inhibitor VX-765 Protects the Isolated Rat Heart via the RISK Pathway
- (2018) Helison Do Carmo et al. CARDIOVASCULAR DRUGS AND THERAPY
- Double-Strand DNA Sensing Aim2 Inflammasome Regulates Atherosclerotic Plaque Vulnerability
- (2018) Nicole Paulin et al. CIRCULATION
- OUP accepted manuscript
- (2018) EUROPEAN HEART JOURNAL
- The TWIK2 Potassium Efflux Channel in Macrophages Mediates NLRP3 Inflammasome-Induced Inflammation
- (2018) Anke Di et al. IMMUNITY
- The Pore-Forming Protein Gasdermin D Regulates Interleukin-1 Secretion from Living Macrophages
- (2018) Charles L. Evavold et al. IMMUNITY
- Evidence that NLRC4 Inflammasome Mediates Apoptotic and Pyroptotic Microglial Death Following Ischemic Stroke
- (2018) Luting Poh et al. BRAIN BEHAVIOR AND IMMUNITY
- IL-1 Blockade in Patients With Heart Failure With Preserved Ejection Fraction
- (2018) Benjamin W. Van Tassell et al. Circulation-Heart Failure
- Interleukin-1β Maturation Triggers Its Relocation to the Plasma Membrane for Gasdermin-D-Dependent and -Independent Secretion
- (2018) Mercedes Monteleone et al. Cell Reports
- Immune mechanisms in heart failure
- (2017) Yingying Zhang et al. EUROPEAN JOURNAL OF HEART FAILURE
- NLR members NLRC4 and NLRP3 mediate sterile inflammasome activation in microglia and astrocytes
- (2017) Leslie Freeman et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- NLRP3 inflammasome activation during myocardial ischemia reperfusion is cardioprotective
- (2016) Ø. Sandanger et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Inhibition of the NLRP3 inflammasome limits the inflammatory injury following myocardial ischemia–reperfusion in the mouse
- (2016) Stefano Toldo et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Interleukin-1 Blockade in Acute Decompensated Heart Failure
- (2016) Benjamin W. Van Tassell et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Pore-forming activity and structural autoinhibition of the gasdermin family
- (2016) Jingjin Ding et al. NATURE
- AIM2 inflammasome is activated by pharmacological disruption of nuclear envelope integrity
- (2016) Antonia Di Micco et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cadmium induces NLRP3 inflammasome-dependent pyroptosis in vascular endothelial cells
- (2016) Haiyan Chen et al. TOXICOLOGY LETTERS
- Innate Immune Pattern Recognition: A Cell Biological Perspective
- (2015) Sky W. Brubaker et al. Annual Review of Immunology
- Early Hyperlipidemia Promotes Endothelial Activation via a Caspase-1-Sirtuin 1 PathwaySignificance
- (2015) Ying Yin et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Activation in M1 but not M2 Macrophages Contributes to Cardiac Remodeling after Myocardial Infarction in Rats: a Critical Role of the Calcium Sensing Receptor/NRLP3 Inflammasome
- (2015) Wenxiu Liu et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Pharmacologic Inhibition of the NLRP3 Inflammasome Preserves Cardiac Function After Ischemic and Nonischemic Injury in the Mouse
- (2015) Carlo Marchetti et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Expression of the NLRP3 Inflammasome in Carotid Atherosclerosis
- (2015) Xin Shi et al. Journal of Stroke & Cerebrovascular Diseases
- The war against heart failure: the Lancet lecture
- (2015) Eugene Braunwald LANCET
- Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death
- (2015) Jianjin Shi et al. NATURE
- AIM2 and NLRC4 inflammasomes contribute with ASC to acute brain injury independently of NLRP3
- (2015) Adam Denes et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Expression of the NLRP3 Inflammasome in Carotid Atherosclerosis
- (2015) Xin Shi et al. Journal of Stroke & Cerebrovascular Diseases
- Interleukin-18 mediates interleukin-1-induced cardiac dysfunction
- (2014) Stefano Toldo et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- The effect of interleukin-1 receptor antagonist therapy on markers of inflammation in non-ST elevation acute coronary syndromes: the MRC-ILA Heart Study
- (2014) A. C. Morton et al. EUROPEAN HEART JOURNAL
- Cutting Edge: Priming of NK Cells by IL-18
- (2014) J. Chaix et al. JOURNAL OF IMMUNOLOGY
- Inflammasomes and Metabolic Disorders: Old Genes in Modern Diseases
- (2014) Gregory R. Robbins et al. MOLECULAR CELL
- MicroRNA-30d regulates cardiomyocyte pyroptosis by directly targeting foxo3a in diabetic cardiomyopathy
- (2014) X Li et al. Cell Death & Disease
- Sudden Cardiac Death Among Firefighters ≤45 Years of Age in the United States
- (2013) Justin Yang et al. AMERICAN JOURNAL OF CARDIOLOGY
- Effects of Interleukin-1 Blockade With Anakinra on Adverse Cardiac Remodeling and Heart Failure After Acute Myocardial Infarction [from the Virginia Commonwealth University-Anakinra Remodeling Trial (2) (VCU-ART2) Pilot Study]
- (2013) Antonio Abbate et al. AMERICAN JOURNAL OF CARDIOLOGY
- Effects of Interleukin-1 Blockade With Anakinra on Aerobic Exercise Capacity in Patients With Heart Failure and Preserved Ejection Fraction (from the D-HART Pilot Study)
- (2013) Benjamin Wallace Van Tassell et al. AMERICAN JOURNAL OF CARDIOLOGY
- Pirfenidone Attenuates Cardiac Fibrosis in a Mouse Model of TAC-Induced Left Ventricular Remodeling by Suppressing NLRP3 Inflammasome Formation
- (2013) Yongliang Wang et al. CARDIOLOGY
- The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia–reperfusion injury
- (2013) Øystein Sandanger et al. CARDIOVASCULAR RESEARCH
- Interleukin-1β induces a reversible cardiomyopathy in the mouse
- (2013) Benjamin W. Van Tassell et al. INFLAMMATION RESEARCH
- A Novel Pharmacologic Inhibitor of the NLRP3 Inflammasome Limits Myocardial Injury After Ischemia–Reperfusion in the Mouse
- (2013) Carlo Marchetti et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Inflammation-related induction of absent in melanoma 2 (AIM2) in vascular cells and atherosclerotic lesions suggests a role in vascular pathogenesis
- (2013) Maani Hakimi et al. JOURNAL OF VASCULAR SURGERY
- IPAF inflammasome is involved in interleukin-1β production from astrocytes, induced by palmitate; implications for Alzheimer's Disease
- (2013) Li Liu et al. NEUROBIOLOGY OF AGING
- Caspase-1 Deficiency Decreases Atherosclerosis in Apolipoprotein E-Null Mice
- (2012) Jessica Gage et al. CANADIAN JOURNAL OF CARDIOLOGY
- Low-Dose Colchicine for Secondary Prevention of Cardiovascular Disease
- (2012) Stefan M. Nidorf et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Enhanced Interleukin-1 Activity Contributes to Exercise Intolerance in Patients with Systolic Heart Failure
- (2012) Benjamin W. Van Tassell et al. PLoS One
- Interleukin-1 Blockade With Anakinra to Prevent Adverse Cardiac Remodeling After Acute Myocardial Infarction (Virginia Commonwealth University Anakinra Remodeling Trial [VCU-ART] Pilot Study)
- (2010) Antonio Abbate et al. AMERICAN JOURNAL OF CARDIOLOGY
- Interleukin-18 as a Predictor of Future Events in Patients With Acute Coronary Syndromes
- (2010) Marianne Hartford et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- BAY 11-7082, a Nuclear Factor-κB Inhibitor, Reduces Inflammation and Apoptosis in a Rat Cardiac Ischemia-Reperfusion Injury Model
- (2010) Yong Sook Kim et al. International Heart Journal
- NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
- (2010) Peter Duewell et al. NATURE
- Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria
- (2010) Edward A Miao et al. NATURE IMMUNOLOGY
- AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC
- (2009) Veit Hornung et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation